Your session is about to expire
← Back to Search
Estrogen for Reperfusion Injury in Kidney Transplant Patients (PERT Trial)
PERT Trial Summary
This trial will study the effects of estrogen on female kidney transplant patients in order to reduce ischemia perfusion injury.
PERT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPERT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PERT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have experienced a severe allergic reaction or swelling to Premarin Intravenous therapy.I have been on dialysis for at least 1 month before my transplant.I have had cancer that is sensitive to estrogen like breast, endometrial, or ovarian cancer.I am female.I am getting a kidney transplant from a deceased donor with a KDPI over 40.You have a history of certain conditions that make your blood more likely to clot.I had a stroke or heart attack in the last 6 months.I am currently taking estrogen or anti-estrogen medications.I am older than 21 years.I cannot take certain blood thinning medication due to an allergy or other medical reasons.I have had a solid organ transplant.I am receiving a multi-organ transplant.You have a BMI higher than 40.I have had a deep vein thrombosis or pulmonary embolism in the past.My doctor thinks I can't handle a certain medicine dose during transplant.
- Group 1: Active Arm
- Group 2: Placebo Arm
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the Active Arm clinical trial a new development?
"As of now, there are a total of 165 ongoing clinical trials investigating Active Arm. Out of these studies, 39 are currently in Phase 3. The majority of research sites for Active Arm are based in Calgary, Alberta; however, there are 1133 different locations running clinical trials for Active Arm."
Are we looking for more participants in this trial?
"The trial, which was first announced on August 26th 2016, is still recruiting patients according to the latest information available."
What is Active Arm traditionally used to treat?
"Active Arm is a medication used to treat electrolyte levels, parenteral nutrition, regional citrate anticoagulation (RCA), and skin irritation."
How many people are signing up for this clinical trial?
"That is accurate. The information available on clinicaltrials.gov indicates that the trial is currently ongoing and recruiting patients. 30 individuals are needed for the study, which is taking place at a single site."
Share this study with friends
Copy Link
Messenger